tiprankstipranks
Advertisement
Advertisement

GH Stock Latest News

Guardant Health price target raised to $185 from $175 at Morgan Stanley
The FlyGuardant Health price target raised to $185 from $175 at Morgan Stanley
13d ago
GH
Guardant Health price target raised to $195 from $170 at Stephens
PremiumThe Fly
Guardant Health price target raised to $195 from $170 at Stephens
13d ago
GH
Guardant Health price target raised to $193 from $135 at Piper Sandler
PremiumThe Fly
Guardant Health price target raised to $193 from $135 at Piper Sandler
13d ago
GH
Guardant Health: Buy Rating Reiterated as Strong Q2 Results, Raised 2026 Outlook Support Unchanged $205 Price Target
PremiumRatings
Guardant Health: Buy Rating Reiterated as Strong Q2 Results, Raised 2026 Outlook Support Unchanged $205 Price Target
14d ago
GH
Guardant Health price target raised to $180 from $130 at Stifel
PremiumThe Fly
Guardant Health price target raised to $180 from $130 at Stifel
14d ago
GH
Guardant Health Earnings Call Highlights Aggressive Growth
PremiumCompany AnnouncementsGuardant Health Earnings Call Highlights Aggressive Growth
16d ago
GH
Guardant Health price target raised to $200 from $185 at RBC Capital
Premium
The Fly
Guardant Health price target raised to $200 from $185 at RBC Capital
17d ago
GH
Guardant Health price target raised to $210 from $200 at TD Cowen
Premium
The Fly
Guardant Health price target raised to $210 from $200 at TD Cowen
17d ago
GH
Guardant Health price target raised to $195 from $190 at BTIG
PremiumThe Fly
Guardant Health price target raised to $195 from $190 at BTIG
17d ago
GH
Guardant Health price target raised to $195 from $185 at JPMorgan
PremiumThe Fly
Guardant Health price target raised to $195 from $185 at JPMorgan
17d ago
GH
Guardant Health price target raised to $200 from $175 at Mizuho
PremiumThe Fly
Guardant Health price target raised to $200 from $175 at Mizuho
17d ago
GH
Guardant Health price target raised to $210 from $185 at Goldman Sachs
PremiumThe Fly
Guardant Health price target raised to $210 from $185 at Goldman Sachs
17d ago
GH
Guardant Health price target raised to $200 from $150 at Barclays
PremiumThe FlyGuardant Health price target raised to $200 from $150 at Barclays
17d ago
GH
Closing Bell Movers: Apple slides 6% after soft guidance
Premium
The Fly
Closing Bell Movers: Apple slides 6% after soft guidance
17d ago
GH
MU
Guardant Health files automatic mixed securities shelf
Premium
The Fly
Guardant Health files automatic mixed securities shelf
17d ago
GH
Guardant Health reports Q2 adjusted EPS (42c), consensus (39c)
PremiumThe Fly
Guardant Health reports Q2 adjusted EPS (42c), consensus (39c)
17d ago
GH
Guardant Health raises FY26 revenue view to $1.34B-$1.36B from $1.3B-$1.32B
PremiumThe Fly
Guardant Health raises FY26 revenue view to $1.34B-$1.36B from $1.3B-$1.32B
17d ago
GH
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
PremiumTipRanks Newswire
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
1M ago
GH
JTAI
Guardant Health price target raised to $190 from $160 at Guggenheim
PremiumThe Fly
Guardant Health price target raised to $190 from $160 at Guggenheim
1M ago
GH
Guardant Health price target raised to $200 from $127 at TD Cowen
PremiumThe FlyGuardant Health price target raised to $200 from $127 at TD Cowen
1M ago
GH
Guardant Health price target raised to $205 from $135 at Canaccord
Premium
The Fly
Guardant Health price target raised to $205 from $135 at Canaccord
1M ago
GH
Analyst Maintains Guardant Buy Rating, Citing Shield V2’s Competitive Edge and Strong Commercial Momentum in Colorectal Cancer Screening
Premium
Ratings
Analyst Maintains Guardant Buy Rating, Citing Shield V2’s Competitive Edge and Strong Commercial Momentum in Colorectal Cancer Screening
1M ago
GH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >